Effect of Evidence-based Reminders on Use of Antibiotics
NCT ID: NCT02927743
Last Updated: 2016-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8053 participants
INTERVENTIONAL
2015-06-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Intervention to Reduce Inappropriate Prescriptions of Antibiotics for Respiratory Infections in General Practice
NCT00272155
Long Term Effect of General Practitioner Education on Antibiotic Prescribing
NCT01107223
Improving Antibiotic Use in Acute Care Treatment
NCT00144040
Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)
NCT00132860
Improving Antibiotic Prescribing Practices in Mexican Primary Care Clinics
NCT00989482
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
One of the key strategies to curb the development of antibiotic resistance is to promote intervention at primary care level as more than 90% of antibiotics are prescribed by general practitioners - especially in patients suffering from respiratory tract infections.
The main bacteria causing respiratory tract infections are S. pneumoniae y Haemophilus influenzae. The first one is associated with a significant increase in morbidity and mortality in Latin America.
Approximately 80% of respiratory tract infections have a viral cause, are harmless and self-limiting and in most cases patients recover without specific treatment. Antibiotic treatment is superfluous and in some cases even harmful because of side effects.
Infections caused by resistant bacteria leads to increased mortality, prolonged hospital stay and social collateral damage. Therefore, in 2013 the World Economic Forum pointed out antibiotic resistance as one of the three most important threats to economic and social development.
The World Health Organisation (WHO) launched in 20121 a global strategy to hold back antimicrobial resistance. According to this strategy "the battle against infectious diseases is far from being over. Not only do they continue to cause a large number of infections and deaths, particularly in developing countries, but the emergence and spread of antimicrobial resistance is now also threatening to undermine our ability to treat infections and save lives". The WHO has proposed a number of initiatives against the emergence of resistant bacteria, including interventions to promote proper use of antibiotics.
HAPPY AUDIT II (HA-II) - PART OF THE SOLUTION
HAPPY AUDIT - II is the second phase of HAPPY AUDIT - I, which was a project funded by the European Union to promote appropriate use of antibiotics in 6 countries with a very heterogeneous pattern of consumption of antibiotics and prevalence of resistant strains.
440 general practitioners registered data in winter 2008 and 2009. Inappropriate antibiotic use was reduced by 10% and in pathologies such as acute bronchitis, there was a 50% reduction in use of antibiotics.
In Argentina, 48 general practitioners participated in the whole process and reached a 30% reduction of unnecessary prescriptions of antibiotics in patients with acute bronchitis, sinusitis and pharyngitis.
The positive experience of the first phase has shown the importance and the potential to spread the project to other provinces of Argentina and other South American countries. Our prior knowledge will be used in the HAPPY AUDIT II SOUTH AMERICA to plan interventions for patients and GPs through the methodology APO (Audit Project Odense) which is based on:
1. self-reflection of physicians and group discussion on their prescription patterns,
2. patient education,
3. Development of a multi-faceted intervention.
The overall purpose of the project is to promote the rational use of antibiotics. This will be achieved through the following specific objectives:
1. Preparation of intervention materials for patients and professionals.
2. Implementation of APO cycles in 4 countries.
3. Initial registration of GPs and use of antibiotics for their RTI patients.
4. Analysis of the results of the first registration to identify quality problems in prescription.
5. Development of a multifaceted intervention.
6. Implementation of a cluster randomized control trial to assess the effect of the intervention.
7. Final registration to evaluate the effect of the intervention.
PROJECT ORGANIZATION
180 GPs will participate: Argentina 80 physicians, Bolivia 30 physicians, Paraguay 40 physicians and Uruguay 30 physicians.
The investigators will use the APO methodology, which based on a "bottom-up" approach seeks to change practice behaviour among GPs. The GPs voluntarily participate and set their own quality criteria in order to improve the quality of their own service.
The APO method includes:
* Initial registration of GPs own activities (3 weeks)
* Intervention (online evidence-based reminders during final registration)
* Final registration and evaluation (3 weeks)
Schedule 2014
February - May 2014 - coordinators and researchers first meeting
June - August 2014 - First audit registration during 15 days.
October 2014 - Coordinators and researchers second meeting
March 2015 - Meeting with General Practitioners from all provinces and/ or countries. This meeting will be divided into two parts:
1. Discussion of the results from the first registration;
2. Discussion about the use of quality indicators to decrease inappropriate use of antibiotics.
June - August 2015 - Second registration, intervention (online weekly feedback on evidence-based management of respiratory tract infections)
November 2016 - Assessment of the intervention.
April 2017 - Publication of results
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
evidence-based online feedback
During three months GPs will receive weekly feedback about evidence-based management of respiratory tract infections. In order to control that they read the material, there is a questionnaire, they have to fill in every week
evidence-based online feedback
GPs received during three months weekly mails about evidence-based practice and a small questionnaire to reflect about their practice and the new knowledge
control
GPs will register data without receiving online feed-back
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
evidence-based online feedback
GPs received during three months weekly mails about evidence-based practice and a small questionnaire to reflect about their practice and the new knowledge
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with suspected respiratory tract infection
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gloria Cristina Cordoba
OTHER
Society of Family Medicin La Paz-Bolivia
UNKNOWN
University of Itapua, Paraguay
UNKNOWN
University of the Republic, Uruguay
OTHER
Society of General and Family practice, Misiones- Argentina
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gloria Cristina Cordoba
MD-MPH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HAPPY-AUDIT II/cRCT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.